Researchers at Stanford Medicine discovered the mechanism for a heart condition and developed a drug to treat it.
Category: Drug Development
Machine learning could enable faster, less costly epilepsy drugs
Researchers created an algorithm to determine if mice have epilepsy and whether they have been treated with seizure drugs.
Cancer-detecting wearable may offer better way to monitor tumors
Researchers from Stanford have developed a wearable sensor to monitor the size of tumors, which could assist new cancer drug evaluations.
Molecular movie maker
Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.
Stanford Medicine magazine explores the molecules within us
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Preparing for the viruses we’ve yet to meet
Researchers at Stanford Medicine are working to develop antivirals to stop the current pandemic and prevent ones.
Bringing principles of ethics to AI and drug design
Researchers discuss the need for ethics and its integration into research projects that harness artificial intelligence.
Engineered tissue sent into space to test muscle loss drugs
To help us understand muscle loss as we age, a Stanford Medicine research team’s engineered tissue is sent to the International Space Station.
Keeping treatment-resistant skin cancer cells in check
Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.
Computer simulation may yield new COVID-19 drug
Stanford Medicine researchers have discovered a drug that could potentially be used to stave off SARS-CoV-2, the virus that causes COVID-19.
Stanford’s new Innovative Medicines Accelerator is already contributing to COVID-19 effort — and much more is planned
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
Lyme disease bacteria eradicated by new drug in early tests
A study provides evidence that the drug azlocillin eliminates the bacteria that cause Lyme disease at the onset of infection in lab mice and cultures.
On the importance of culture, partnerships and diversity at the Dean’s Lecture Series
At a recent Dean's Lecture Series, Dean Lloyd Minor discussed organizational culture and diversity with Emma Walmsley, CEO of GlaxoSmithKline.
Anti-CD47 antibody trial in advanced cancers shows treatment appears safe, well-tolerated
An antibody against the "don't eat me" signal on cancer cells appears safe and well-tolerated by patients with advanced cancers. A phase 2 trial is planned.
For patients on antidepressants, a common opioid is less effective
Patients who are taking the most common type of antidepressant may feel more pain when taking certain opioids, Stanford researchers have found.
Compound identified that may help treat heart failure
Stanford researchers have discovered a compound that reduces the symptoms of heart failure after a heart attack in initial animal tests.